NCT05278624View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

February 17, 2023

Study Completion Date

February 17, 2023

Conditions

Rosacea

Interventions

DRUG

Roflumilast Cream

Topical Cream

Trial Locations (1)

27262

Dermatology Consulting Services, PLLC, High Point

All Listed Sponsors

lead

Dermatology Consulting Services, PLLC

NETWORK